HOME >> MEDICINE >> NEWS
Invitation to take part in one-on-one interviews with experts on Avandia

36th European Association for the Study of Diabetes (EASD) Annual Meeting, 17-21 September, 2000

On behalf of SmithKline Beecham we are delighted to be able to offer you exclusive interviews with leading experts on Avandia.

Monday 18 September, 2000
Tuesday 19 September, 2000

  • With the European approval of Avandia, SmithKline Beecham's new oral anti-diabetic agent, a new treatment option is available to patients with inadequately controlled type 2 diabetes.

  • Avandia is the first thiazolidinedione to receive centralized approval across the 15 countries of the European Union and has been approved in over 50 countries worldwide.

  • Avandia has been linked with improvements in -cell function and reductions in insulin resistance, both fundamental causes of type 2 diabetes.

  • To date, over 4 million Avandia prescriptions have been dispensed to over a million patients in the US alone.

We are delighted to be able to offer you the opportunity to interview some of the world's leading experts in diabetes in exclusive one-on-one interviews.


'"/>

Contact: Chloe Murray
chloe@meditech.co.uk
44-20-7398-0500
MediTech Media Ltd.
4-Sep-2000


Page: 1

Related medicine news :

1. Failure to count Iraqi casualties is irresponsible, say experts
2. International gathering of experts to share retinoblastoma breakthroughs
3. Injury toll in US homes tops 12 million yearly: UNC, other experts call for action
4. Assessing the season: LSU hurricane experts learned lessons during Hurricane Season 2004
5. Anniversary of one of the largest hepatitis A outbreaks in the US brings experts together
6. Rice cartilage experts win $1.5M NIH grant to bioengineer TMJ discs
7. Leading MRSA experts address emergence of superbug
8. Chest 2004 hosts world experts in pulmonary, sleep, and critical care medicine
9. Tobacco sponsorship of Formula One must stop, say health experts
10. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants
11. International experts discuss latest research on vitamin E & health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... January 16, 2017 , ... Vixiar Medical, ... of the medical device company, effective immediately. , “This is perfect timing for ... a strong track record in medical device market development and revenue growth, particularly ...
(Date:1/15/2017)... ... 2017 , ... Whole Health Supply, LLC is announcing the release of an updated version of ... purchase. , The 2017 edition has wide jaws that will accommodate nails up to ... well as diabetics. This handle is reinforced for extra strength when pressing down on dense ...
(Date:1/15/2017)... ... January 14, 2017 , ... Wondering where to go this Valentine's ... to your door for a romantic, lobster feast in the comfort of your own ... Day. The dinners will be featured until February 15th, 2017. , Romantic Dinner ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to ... magnesium-rich Mediterranean diet may lower the risk of type 2 diabetes, Alzheimer’s, and ... many health and wellness benefits linked to a Mediterranean diet are only some ...
(Date:1/13/2017)... , ... January 13, 2017 , ... The 18th European ... America hotel on March 3-4, 2017. This Congress is expertly designed to meet ... management of patients with lung cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... , January 16, 2017 Bill is an ... of general management and leadership positions with global medical device companies, ... strong track record of launching new products and building successful businesses ... , Africa and North America ... Educated ...
(Date:1/16/2017)... 2017 CBDRx, the world,s premiere nutraceutical hemp ... rich hemp extract to Veteran,s groups across the country. ... hemp extract to Veteran,s groups across the United States.  ... in the world and through their passion, CBDRx honors ... phyto-nutrient rich hemp extract available. ...
(Date:1/13/2017)... Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), today announced that ... at Eli Lilly & Company, has been appointed to InMed ... years of senior financial and executive leadership to InMed,s Board ... ... leadership position in financial and business expertise with one of ...
Breaking Medicine Technology:
Cached News: